Skip to end of metadata
Go to start of metadata




1a. Project Name

Patient Medication List Guidance

1b. Project ID

1609

1c. Is Your Project an Investigative Project (aka PSS-Lite)?

No

1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?

No

1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Pharmacy

2d. Project Facilitator

Melva Peters

2e. Other Interested Parties (and roles)

2f. Modeling Facilitator

Jean Duteau

2g. Publishing Facilitator

Scott Robertson

2h. Vocabulary Facilitator

Julie James

2i. Domain Expert Representative

John Hatem, Scott Robertson, Melva Peters, Tom deJong

2j. Business Requirements Analyst

Melva Peters

2k. Conformance Facilitator

Melva Peters

2l. Other Facilitators

2m. Implementers

3a. Project Scope

This project will provide guidance on how to define, retrieve and create different types of patient specific medication lists based on context of use. Best practices for FHIR resource use and query parameters will be defined for each type of medication list.

This IG will be based on proposed R5 content and therefore may include some changes to the FHIR Core specification.

It is not expected that this project will define individual fields for display.

Drug formularies, lists of medications, schedules, catalogues are out of scope for this project.

Attachments

3b. Project Need

Medication Lists are a key asset in most electronic medication records and electronic health records, but there is limited agreement on the content of medication lists. The goal of this project is to define some best practices for creating medication lists using HL7 FHIR depending on their context of use.

3c. Security Risk

No

3d. External Drivers

N/A

3e. Objectives/Deliverables and Target Dates

PSS approval - February 29, 2020
FHIR IG proposal approved - March 15, 2020
Content developed - July 31, 2020
NIB submitted - July 5, 2020
Ballot - September 2020 Ballot Cycle
Ballot reconciliation - September 2020 WGM - to be completed by October 31, 2020
Publish - December 31, 2020

3f. Common Names / Keywords / Aliases:

Medication List, Medication Profile, Active Medication List; Medication History

3g. Lineage

3h. Project Dependencies

None

3i. HL7-Managed Project Document Repository URL:

HL7 GitHub - specific URL to be determined

3j. Backwards Compatibility

N/A

3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?

N/A

3l. Reason for not using current V3 data types?

3m. External Vocabularies

No

3n. List of Vocabularies

3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

FHIR Implementation Guide

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

R5

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Revise current standard, Implementation Guide (IG) will be created/modified

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?

No

5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

5b. Project Ballot Type

Informative

5c. Additional Ballot Info

5d. Joint Copyright

No

5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.

no

6a. External Project Collaboration

6b. Content Already Developed

6c. Content externally developed?

No

6d. List Developers of Externally Developed Content

6e. Is this a hosted (externally funded) project?

No

6f. Stakeholders

Regulatory Agency, Standards Development Organizations (SDOs), Payors, Other

6f. Other Stakeholders

Pharmacies
Providers

6g. Vendors

EHR, PHR, Health Care IT, Clinical Decision Support Systems, HIS, Other

6g. Other Vendors

Pharmacy System Vendors
Prescription Exchange Vendors
Portal Vendors
Third Party App vendors
Adjudicating System Vendors
Provider System Vendors

6h. Providers

Healthcare Institutions (hospitals, long term care, home care, mental health), Other

6h. Other Providers

Pharmacies
Payers
Prescribers

6i. Realm

Universal

7d. US Realm Approval Date

7a. Management Group(s) to Review PSS

FHIR

7b. Sponsoring WG Approval Date

Feb 06, 2020

7c. Co-Sponsor Approval Date

7c. Co-Sponsor 2 Approval Date

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

7j. TSC Approval Date